Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151


Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.

Chen DL, Wang ZQ, Ren C, Zeng ZL, Wang DS, Luo HY, Wang F, Qiu MZ, Bai L, Zhang DS, Wang FH, Li YH, Xu RH.

J Transl Med. 2013 Nov 2;11:277. doi: 10.1186/1479-5876-11-277.


Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.

Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, Li YH, Kang TB, Xu RH.

Carcinogenesis. 2013 Apr;34(4):803-11. doi: 10.1093/carcin/bgs400. Epub 2012 Dec 28.


L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.

Chen DL, Zeng ZL, Yang J, Ren C, Wang DS, Wu WJ, Xu RH.

J Hematol Oncol. 2013 Jun 27;6:43. doi: 10.1186/1756-8722-6-43.


Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.

Ito T, Yamada S, Tanaka C, Ito S, Murai T, Kobayashi D, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2014 Feb;21(2):560-8. doi: 10.1245/s10434-013-3246-5. Epub 2013 Sep 18.


Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.

Yu W, Ma S, Wang L, Zuo B, Li M, Qiao Z, Pan X, Liu Y, Wang J.

Histol Histopathol. 2013 Dec;28(12):1629-38. Epub 2013 Jul 9.


Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.

Wu DW, Chuang CY, Lin WL, Sung WW, Cheng YW, Lee H.

Carcinogenesis. 2014 Aug;35(8):1823-9. doi: 10.1093/carcin/bgu102. Epub 2014 Apr 29.


KITENIN is associated with tumor progression in human gastric cancer.

Ryu HS, Park YL, Park SJ, Lee JH, Cho SB, Lee WS, Chung IJ, Kim KK, Lee KH, Kweon SS, Joo YE.

Anticancer Res. 2010 Sep;30(9):3479-86.


Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.

Cheng HC, Liu YP, Shan YS, Huang CY, Lin FC, Lin LC, Lee L, Tsai CH, Hsiao M, Lu PJ.

Carcinogenesis. 2013 Nov;34(11):2452-9. doi: 10.1093/carcin/bgt218. Epub 2013 Jun 17.


Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.

Kim SM, Kwon CH, Shin N, Park do Y, Moon HJ, Kim GH, Jeon TY.

Int J Cancer. 2014 Jan 1;134(1):114-24. doi: 10.1002/ijc.28345. Epub 2013 Jul 16.


NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.

Shi R, Wang L, Wang T, Xu J, Wang F, Xu M.

Med Oncol. 2014 Mar;31(3):852. doi: 10.1007/s12032-014-0852-4. Epub 2014 Jan 28.


Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.


Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.

Wang DD, Chen YB, Pan K, Wang W, Chen SP, Chen JG, Zhao JJ, Lv L, Pan QZ, Li YQ, Wang QJ, Huang LX, Ke ML, He J, Xia JC.

PLoS One. 2012;7(7):e40364. doi: 10.1371/journal.pone.0040364. Epub 2012 Jul 13.


Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.

Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8. Epub 2013 Jan 19.


microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.

Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M.

Oncol Rep. 2012 Apr;27(4):1019-26. doi: 10.3892/or.2012.1645. Epub 2012 Jan 19.


Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.

Cui M, Yu W, Dong J, Chen J, Zhang X, Liu Y.

Med Oncol. 2010 Sep;27(3):632-9. doi: 10.1007/s12032-009-9260-6. Epub 2009 Jun 25.


Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.

Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z.

World J Surg Oncol. 2012 Jun 8;10:103. doi: 10.1186/1477-7819-10-103.


[Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].

Cai SR, Chen CQ, Wang Z, He YL, Cui J, Wu WH, Wu H, Zhan WH.

Zhonghua Yi Xue Za Zhi. 2008 Aug 26;88(33):2326-30. Chinese.


High level of COP1 expression is associated with poor prognosis in primary gastric cancer.

Li YF, Wang DD, Zhao BW, Wang W, Huang CY, Chen YM, Zheng Y, Keshari RP, Xia JC, Zhou ZW.

Int J Biol Sci. 2012;8(8):1168-77. doi: 10.7150/ijbs.4778. Epub 2012 Oct 2.


Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.

Zheng HC, Xu XY, Xia P, Yu M, Takahashi H, Takano Y.

Hum Pathol. 2010 Sep;41(9):1255-64. doi: 10.1016/j.humpath.2010.02.003. Epub 2010 May 5.


Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer.

Okugawa Y, Inoue Y, Tanaka K, Kawamura M, Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y, Kusunoki M.

Clin Exp Metastasis. 2013 Apr;30(4):417-29. doi: 10.1007/s10585-012-9547-4. Epub 2012 Nov 11.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk